MedTrace Logo

Culturally Adapted Family Intervention For Psychosis

NCT02167347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-08-25

No results posted yet for this study

Summary

Aim:

To assess the feasibility of culturally adapted Family Intervention for Psychosis.

Design:

Randomized Control Trial

Setting:

psychiatric department of different hospitals

Participants:

A total of 36 caregivers of Psychosis patients will be randomized to psychological Intervention and treatment as usual arm.

Intervention:

Culturally Adapted Family Intervention for Psychosis

Outcome measure:

Positive and Negative syndrome scale (PANSS) Experience of care -giving inventory(ECI) Care Well-Being \& Support(CWS)

Conditions

Interventions

BEHAVIORAL

Family intervention

This 10 session Multi-modal Psychosocial Intervention will include a supportive component, an educational component, psychosocial component

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Dow University of Health Sciences

    collaborator OTHER

  • Abbasi Shaheed Hospital

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain, MD · Pakistan Institute of Learning and Living, University of Manchester

  • Imran Chaudhry, MD · University of Manchester

  • Farooq Naeem, MRCPsych · Pakistan Institute of Learning and Living, University of Southampton

  • Raza Ur Rehman, FCPS · Dow University of Health Sciences

  • Ajmal kazm · Pakistan Institute of Living and Learning

  • Munir Hamirani, FCPS · Abbasi Shaheed Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-07-31
Completion
2014-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02167347 on ClinicalTrials.gov